Abstract:Variants within non-coding genomic regions can greatly affect disease. In recent years, increasing focus has been given to these variants, and how they can alter regulatory elements, such as enhancers, transcription factor binding sites and DNA methylation regions. Such variants can be considered regulatory variants. Concurrently, much effort has been put into establishing international consortia to undertake large projects aimed at discovering regulatory elements in different tissues, cell lines and organisms, and probing the effects of genetic variants on regulation by measuring gene expression. Here, we describe methods and techniques for discovering disease-associated non-coding variants using sequencing technologies. We then explain the computational procedures that can be used for annotating these variants using the information from the aforementioned projects, and prediction of their putative effects, including potential pathogenicity, based on rule-based and machine learning approaches. We provide the details of techniques to validate these predictions, by mapping chromatin-chromatin and chromatin-protein interactions, and introduce Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 (CRISPR-Cas9) technology, which has already been used in this field and is likely to have a big impact on its future evolution. We also give examples of regulatory variants associated with multiple complex diseases. This review is aimed at bioinformaticians interested in the characterization of regulatory variants, molecular biologists and geneticists interested in understanding more about the nature and potential role of such variants from a functional point of views, and clinicians who may wish to learn about variants in non-coding genomic regions associated with a given disease and find out what to do next to uncover how they impact on the underlying mechanisms.

Deep learning approaches for non-coding genetic variant effect prediction: current progress and future prospects

Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk

A comprehensive review of deep learning-based variant calling methods

A semi-supervised deep learning approach for predicting the functional effects of genomic non-coding variations

Multimodal learning of noncoding variant effects using genome sequence and chromatin structure

Exploring noncoding variants in genetic diseases: From detection to functional insights

Combining Artificial Intelligence: Deep Learning with Hi-C Data to Predict the Functional Effects of Non-Coding Variants.

Progress on deep learning in genomics

Deep Learning in Regulatory Genomics: from Identification to Design.

Exploring Functional Variant Using a Deep Learning Framework

A Comparison on Predicting Functional Impact of Genomic Variants.

Predicting Functional Elements and Variants Effects in Non-Coding Regions Based on Deep Learning

Regulatory variants: from detection to predicting impact

Training deep learning models on personalized genomic sequences improves variant effect prediction

Prediction of disease-associated functional variants in noncoding regions through a comprehensive analysis by integrating datasets and features

Deep Learning for Genomics: From Early Neural Nets to Modern Large Language Models

Application of deep learning in genomics

Scalable approaches for functional analyses of whole-genome sequencing non-coding variants

Deep-learning prediction of gene expression from personal genomes

How chromatin interactions shed light on interpreting non-coding genomic variants: opportunities and future direc-tions

Predicting the Functional Effects of Human Non-Coding Variants Based on Stacking Ensemble Learning.